BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32718068)

  • 1. The Biological and Clinical Role of the Long Non-Coding RNA LOC642852 in Ovarian Carcinoma.
    Filippov-Levy N; Reich R; Davidson B
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
    Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
    Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.
    Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biological Role of the Long Non-coding RNA
    Filippov-Levy N; Davidson B; Reich R
    Anticancer Res; 2020 Dec; 40(12):6677-6684. PubMed ID: 33288561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical role of long non-coding RNA in high-grade serous carcinoma.
    Filippov-Levy N; Cohen-Schussheim H; Tropé CG; Hetland Falkenthal TE; Smith Y; Davidson B; Reich R
    Gynecol Oncol; 2018 Mar; 148(3):559-566. PubMed ID: 29310950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer.
    Zhang LQ; Yang SQ; Wang Y; Fang Q; Chen XJ; Lu HS; Zhao LP
    Anal Cell Pathol (Amst); 2017; 2017():8267863. PubMed ID: 28168162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
    Qu C; Dai C; Guo Y; Qin R; Liu J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
    Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X
    Gene; 2019 Sep; 713():143969. PubMed ID: 31299360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
    Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
    Yang Q; Yu Y; Sun Z; Pan Y
    Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ; Yang JB
    Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer.
    Liang H; Zhao X; Wang C; Sun J; Chen Y; Wang G; Fang L; Yang R; Yu M; Gu Y; Shan H
    Mol Cancer; 2018 Jun; 17(1):96. PubMed ID: 29929545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
    Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
    Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21.
    Zhao J; Zhang C; Gao Z; Wu H; Gu R; Jiang R
    J Cell Biochem; 2018 Aug; 119(8):6461-6469. PubMed ID: 29323740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.